Skip to content

Efficacy of artificial intelligence–assisted embryo selection in improving live birth rate among couples with recurrent implantation failure: an exploratory randomized controlled clinical trial

Efficacy of artificial intelligence–assisted embryo selection in improving live birth rate among couples with recurrent implantation failure: an exploratory randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127745
Enrollment
Unknown
Registered
2026-07-07
Start date
2026-07-08
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent implantation failure

Interventions

Morphology-only group:Morphological embryo selection
IDAScore group:IDAScore embryo scoring combined with morphological embryo selection

Sponsors

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Infertile women with a history of RIF, RIF refers to failure to achieve a clinical pregnancy (including Biochemical pregnancy abortion) after one of the following conditions: (1) 3 or more embryo transfer cycles (2) 2 embryo transfer cycles where no less than 3 embryos were transferred cumulatively; 2. Women aged 20-40 years at the time of OPU; 3. Women with at least 2 blastocysts; 4.Be capable of giving informed consent.

Exclusion criteria

Exclusion criteria: 1.Women with a uterine cavity abnormality, such as a uterine congenital malformation (uterus unicornate, bicornate, or duplex) , untreated uterine septum, submucous myoma, multiple endometrial polyp(s) or with a history of severe intrauterine adhesions, with untreated hydrosalpinx, with thin endometrium (< 6 mm on the trigger day). 2.Women who are indicated and planned to undergo PGT-A, PGT-M or PGT-SR; 3.Women who use donated oocytes to achieve pregnancy; 4.Women with medical contraindications to assisted reproductive technology and/or pregnancy.

Design outcomes

Primary

MeasureTime frame
Live birth after the first embryo transfer cycle;

Secondary

MeasureTime frame
Neonatal complications, birth weight and birth defects;Biochemical pregnancy;Complications during pregnancy and childbirth;Good birth outcome;Pregnancy loss;Clinical pregnancy;

Countries

China

Contacts

Public ContactHuang Jia'an

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

huangjiaan@renji.com+86 21 20284574

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026